SGB Inc
BioTech/Drugs - Summit, NJ, US
SGB Inc Employees
SGB Inc Details
VentiRx is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like Receptor 8 (TLR8) immunotherapies for the treatment of cancer, respiratory and inflammatory diseases. VentiRx has a broad clinical pipeline. The lead clinical oncology asset, VTX-2337, is a small molecule TLR8 agonist, currently in multiple clinical trials in combination with chemotherapies and monoclonal antibodies. The company has entered into a worldwide strategic collaboration with Celgene Corporation for this program.
Website:
sgbiofuels.com
Employees:
20 - 49
HQ:
760-718-3120
Location:
Summit, NJ, US
Revenue:
10 - 20 Million
SGB Inc Technologies
Domain Name Services
CSC Corporate Domains
SSL Certificates
Media Temple SSL